Antares Pharma, Announce Earnings
Antares Pharma (ATRS) announced that its loss in the fourth-quarter increased to $5 million, or 4 cents per share, versus a loss of $154,000, or less than one cent per share in the final quarter of 2011, when it had fewer shares outstanding. Revenue increased by one percent to $5.5 million.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here